<code id='E059E17CD8'></code><style id='E059E17CD8'></style>
    • <acronym id='E059E17CD8'></acronym>
      <center id='E059E17CD8'><center id='E059E17CD8'><tfoot id='E059E17CD8'></tfoot></center><abbr id='E059E17CD8'><dir id='E059E17CD8'><tfoot id='E059E17CD8'></tfoot><noframes id='E059E17CD8'>

    • <optgroup id='E059E17CD8'><strike id='E059E17CD8'><sup id='E059E17CD8'></sup></strike><code id='E059E17CD8'></code></optgroup>
        1. <b id='E059E17CD8'><label id='E059E17CD8'><select id='E059E17CD8'><dt id='E059E17CD8'><span id='E059E17CD8'></span></dt></select></label></b><u id='E059E17CD8'></u>
          <i id='E059E17CD8'><strike id='E059E17CD8'><tt id='E059E17CD8'><pre id='E059E17CD8'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:4298

          Who gets to sue the FDA? Is pharma caught in a trade war? And what does “AF” stand for?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Sarah Owermohle joins us to explain the Supreme Court case that could have dramatic effects on access to medication abortion — and the development of new medicines. We also discuss the latest news in the life sciences, including a contrarian take on a new obesity treatment, a congressional effort to ban Chinese biotech companies, and how we managed to make 300 episodes of this podcast.

          advertisement

          For more on what we cover, here’s the latest on the mifepristone case; here’s where you can find Adam’s newsletter; here’s more on WuXi and Congress; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal
          Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

          CourtesySanofiLONDON—Inabidtoexpanditspipelineofinflammation-targetingdrugs,SanofisaidTuesdayitwasac

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          HPV vaccine, cervical cancer study delivers historic results

          AnursedeliversadoseoftheHPVvaccineatacollegewesternFranceinOctober2023.DAMIENMEYER/AFPviaGettyImages